Telehealth platform Hims & Hers Health, Inc. (HIMS), which connects consumers to healthcare professionals, is at a crossroads ...

Novo Holdings, the controlling shareholder of obesity drugmaker Novo Nordisk, nearly doubled annual income and investment ...

Eli Lilly (LLY) is taking legal action against makers of off-brand versions of its blockbuster diabetes and weight-loss drugs ...

LAURA CRAIK looks into a new trend where designer brands are turning commonplace items into designer must-haves by slapping a ...

Lexicon Pharmaceuticals, headquartered in The Woodlands, announced it will exclusively license its drug LX9851 to the maker ...

Jeremy Clarkson shared his expensive dieting trick after swearing off Ozempic. The Grand Tour star, 64, explained that he ...

Novo Nordisk (NVO) presented results from STRIDE, its phase 3b trial investigating the effects of once-weekly Ozempic injection 1 mg in adults ...

The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart ...